Sopharma Sees Weaker Sales in June This Year

612
In June this year Sopharma's sales () on the domestic market equaled just 90.56% of the amount achieved last year. The company also reported 93.06% of the export and 91.87% of the total sales amount, compared with 2007, x3news informs.

The slightly weaker results are due to the specificities of the market situation during the period, the company said.

Sales revenues in H1 are up 3.43%, including a 17.96% in foreign currency terms.

Another factor limiting the company's sales is the continuing reconstruction of the ampule production department. In spite of that, Sopharma said the overall trend is positive.

12,034 shares traded hands today on BSE. The last deal was at 5.98%, which is 3.02% up from opening. The average for the at settled at 5.83 leva.

Facebook Коментари

Добави коментар

Екипът на Profit.bg Ви благодари, че използвате кирилица за вашите коментари.
В случай, че коментарът Ви съдържа нецензурни квалификации и лични нападки или обиди на расова, сексуална, етническа или верска основа, той ще бъде изтрит от модератора на сайта.

Абонирайте се за електронния
информационен бюлетин на Profit.bg